Existing relationships
 
The Therabel Group is involved in numerous strategic alliances concerning the development and research of new drugs as well as promotion of products under license or distribution.
 
As regards Italy, Therabel GiEnne has License agreements with the following partners:
- GEBRO PHARMA (Austria): Seractil
- BONISCONTRO & GAZZONI (Italia)
  Magaltop

Development objectives
 
The main objective of Therabel Gienne concerns the study of products to be included in our strategic areas as well as evaluation of new programs aimed at extending our products portfolio, also through Research and Development agreements with qualified partners.

> Contact the Director of Marketing & Business Development